Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

FF vs BIOX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FF
FutureFuel Corp.

Chemicals

Basic MaterialsNYSE • US
Market Cap$211M
5Y Perf.-63.3%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$30M
5Y Perf.-92.9%

FF vs BIOX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FF logoFF
BIOX logoBIOX
IndustryChemicalsAgricultural Inputs
Market Cap$211M$30M
Revenue (TTM)$96M$318M
Net Income (TTM)$-49M$-53M
Gross Margin0.1%39.1%
Operating Margin-55.3%0.2%
Total Debt$0.00$277M
Cash & Equiv.$51M$33M

FF vs BIOXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FF
BIOX
StockMay 20May 26Return
FutureFuel Corp. (FF)10036.7-63.3%
Bioceres Crop Solut… (BIOX)1007.1-92.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: FF vs BIOX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FF and BIOX are tied at the top with 3 categories each — the right choice depends on your priorities. Bioceres Crop Solutions Corp. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
FF
FutureFuel Corp.
The Income Pick

FF carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 0.49, yield 0.0%
  • 55.5% 10Y total return vs BIOX's -95.1%
  • Lower volatility, beta 0.49, current ratio 5.67x
Best for: income & stability and long-term compounding
BIOX
Bioceres Crop Solutions Corp.
The Growth Play

BIOX is the clearest fit if your priority is growth exposure.

  • Rev growth -28.3%, EPS growth -17.0%, 3Y rev CAGR 0.5%
  • -28.3% revenue growth vs FF's -60.7%
  • -16.6% margin vs FF's -51.6%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthBIOX logoBIOX-28.3% revenue growth vs FF's -60.7%
Quality / MarginsBIOX logoBIOX-16.6% margin vs FF's -51.6%
Stability / SafetyFF logoFFBeta 0.49 vs BIOX's 1.94
DividendsFF logoFF0.0% yield; the other pay no meaningful dividend
Momentum (1Y)FF logoFF+26.3% vs BIOX's -88.5%
Efficiency (ROA)BIOX logoBIOX-6.7% ROA vs FF's -23.5%, ROIC -0.5% vs -39.8%

FF vs BIOX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FFFutureFuel Corp.
FY 2025
Chemicals
62.2%$60M
Biofuels
37.8%$36M
BIOXBioceres Crop Solutions Corp.

Segment breakdown not available.

FF vs BIOX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBIOXLAGGINGFF

Income & Cash Flow (Last 12 Months)

BIOX leads this category, winning 6 of 6 comparable metrics.

BIOX is the larger business by revenue, generating $318M annually — 3.3x FF's $96M. BIOX is the more profitable business, keeping -16.6% of every revenue dollar as net income compared to FF's -51.6%. On growth, BIOX holds the edge at -16.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…
RevenueTrailing 12 months$96M$318M
EBITDAEarnings before interest/tax-$43M$21M
Net IncomeAfter-tax profit-$49M-$53M
Free Cash FlowCash after capex-$46M$37M
Gross MarginGross profit ÷ Revenue+0.1%+39.1%
Operating MarginEBIT ÷ Revenue-55.3%+0.2%
Net MarginNet income ÷ Revenue-51.6%-16.6%
FCF MarginFCF ÷ Revenue-48.0%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year-67.7%-16.4%
EPS Growth (YoY)Latest quarter vs prior year-5.2%-37.3%
BIOX leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

BIOX leads this category, winning 2 of 3 comparable metrics.
MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…
Market CapShares × price$211M$30M
Enterprise ValueMkt cap + debt − cash$159M$274M
Trailing P/EPrice ÷ TTM EPS-4.25x-0.58x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple20.01x
Price / SalesMarket cap ÷ Revenue2.20x0.09x
Price / BookPrice ÷ Book value/share1.36x0.10x
Price / FCFMarket cap ÷ FCF0.85x
BIOX leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

BIOX leads this category, winning 5 of 7 comparable metrics.

BIOX delivers a -16.7% return on equity — every $100 of shareholder capital generates $-17 in annual profit, vs $-29 for FF.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…
ROE (TTM)Return on equity-28.6%-16.7%
ROA (TTM)Return on assets-23.5%-6.7%
ROICReturn on invested capital-39.8%-0.5%
ROCEReturn on capital employed-51.6%-0.8%
Piotroski ScoreFundamental quality 0–933
Debt / EquityFinancial leverage0.94x
Net DebtTotal debt minus cash-$51M$244M
Cash & Equiv.Liquid assets$51M$33M
Total DebtShort + long-term debt$0$277M
Interest CoverageEBIT ÷ Interest expense-130.01x-0.07x
BIOX leads this category, winning 5 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

FF leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in FF five years ago would be worth $8,308 today (with dividends reinvested), compared to $317 for BIOX. Over the past 12 months, FF leads with a +26.3% total return vs BIOX's -88.5%. The 3-year compound annual growth rate (CAGR) favors FF at 1.2% vs BIOX's -64.0% — a key indicator of consistent wealth creation.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…
YTD ReturnYear-to-date+52.8%-65.0%
1-Year ReturnPast 12 months+26.3%-88.5%
3-Year ReturnCumulative with dividends+3.6%-95.3%
5-Year ReturnCumulative with dividends-16.9%-96.8%
10-Year ReturnCumulative with dividends+55.5%-95.1%
CAGR (3Y)Annualised 3-year return+1.2%-64.0%
FF leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

FF leads this category, winning 2 of 2 comparable metrics.

FF is the less volatile stock with a 0.49 beta — it tends to amplify market swings less than BIOX's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FF currently trades 93.8% from its 52-week high vs BIOX's 9.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…
Beta (5Y)Sensitivity to S&P 5000.49x1.94x
52-Week HighHighest price in past year$5.12$5.18
52-Week LowLowest price in past year$3.09$0.35
% of 52W HighCurrent price vs 52-week peak+93.8%+9.1%
RSI (14)Momentum oscillator 0–10063.344.6
Avg Volume (50D)Average daily shares traded520K804K
FF leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricFF logoFFFutureFuel Corp.BIOX logoBIOXBioceres Crop Sol…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target
# AnalystsCovering analysts4
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.1%
Insufficient data to determine a leader in this category.
Key Takeaway

BIOX leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). FF leads in 2 (Total Returns, Risk & Volatility).

Best OverallBioceres Crop Solutions Cor… (BIOX)Leads 3 of 6 categories
Loading custom metrics...

FF vs BIOX: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is FF or BIOX a better buy right now?

For growth investors, Bioceres Crop Solutions Corp.

(BIOX) is the stronger pick with -28. 3% revenue growth year-over-year, versus -60. 7% for FutureFuel Corp. (FF). Analysts rate FutureFuel Corp. (FF) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — FF or BIOX?

Over the past 5 years, FutureFuel Corp.

(FF) delivered a total return of -16. 9%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: FF returned +55. 5% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — FF or BIOX?

By beta (market sensitivity over 5 years), FutureFuel Corp.

(FF) is the lower-risk stock at 0. 49β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 295% more volatile than FF relative to the S&P 500.

04

Which is growing faster — FF or BIOX?

By revenue growth (latest reported year), Bioceres Crop Solutions Corp.

(BIOX) is pulling ahead at -28. 3% versus -60. 7% for FutureFuel Corp. (FF). On earnings-per-share growth, the picture is similar: FutureFuel Corp. grew EPS -422. 9% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — FF or BIOX?

Bioceres Crop Solutions Corp.

(BIOX) is the more profitable company, earning -15. 5% net margin versus -51. 6% for FutureFuel Corp. — meaning it keeps -15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BIOX leads at -1. 1% versus -55. 3% for FF. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — FF or BIOX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is FF or BIOX better for a retirement portfolio?

For long-horizon retirement investors, FutureFuel Corp.

(FF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 49)). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FF: +55. 5%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between FF and BIOX?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

FF

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform FF and BIOX on the metrics below

Revenue Growth>
%
(FF: -67.7% · BIOX: -16.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.